Starsource Multitrade

Starsource Multitrade Pre-Tax Margin

The Pre-Tax Profit Margin of Starsource Multitrade (506365.BO) as of Oct 27, 2026 is -2,255.26 %. In the previous year, Pre-Tax Profit Margin was -276.75 % — a change of 714.92% (lower).

Pre-Tax Margin

-2,255.26 %

YoY

714.92%

Last updated:

Pre-Tax Profit Margin of Starsource Multitrade is 2026 -2,255.26 % . Pre-Tax Profit Margin of Starsource Multitrade was 2025 -276.75 % . It decreases by 714.92% lower compared to the previous year.

The Starsource Multitrade Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2014
68.76 INR
Jan 1, 2015
76.11 INR
Jan 1, 2016
-276.75 INR
Jan 1, 2026
-2,255.26 INR
The Starsource Multitrade Pre-Tax Margin history
YEARPre-Tax MarginYoY
-2,255.26 %+714.92%
-276.75 %-463.61%
76.11 %+10.69%
68.76 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Starsource Multitrade stock

Pre-Tax Profit Margin of Starsource Multitrade is -2,255.26 % in 2026.

Pre-Tax Profit Margin of Starsource Multitrade changed from -276.75 % to -2,255.26 %, representing a 714.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's Starsource Multitrade with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Starsource Multitrade

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Starsource Multitrade